Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $113.98 | $25.54 | 346.36% | 215.06x | 54.25x | 14.46x | 17.46x | 1.56x | $106.92M | 0.89% | $705.78M | 6.70 | $12.22B | 1,557.61 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $24.39 | $8.69 | 180.82% | 116.14x | 56.72x | 6.86x | 13.90x | 1.00x | $39.15M | 1.23% | $220.58M | 1.69 | $3.15B | 69.29 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $77.09 | $18.40 | 319.04% | 72.05x | 65.95x | 7.11x | 9.19x | 1.84x | $182.84M | 3.06% | $654.15M | 8.43 | $5.85B | 48.75 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $260.10 | $84.22 | 208.84% | 42.64x | 38.34x | 7.23x | 25.70x | 1.50x | $793.95M | 2.28% | $1.35B | 10.14 | $36.08B | 30.59 | ||
| RPRX | ROYALTY PHARMA PLC | $60.59 | $38.25 | 58.41% | 32.23x | 11.31x | 10.63x | 3.56x | 0.65x | $2.92B | 10.84% | $9.79B | 21.99 | $42.99B | 36.55 | ||
| HALO | HALOZYME THERAPEUTICS INC | $108.31 | $72.12 | 50.19% | 30.42x | 11.99x | 7.63x | 85.64x | 0.62x | $806.22M | 6.35% | $143.54M | 1.22 | $14.28B | 19.87 | ||
| KRYS | KRYSTAL BIOTECH INC | $351.26 | $89.53 | 292.33% | 42.47x | 45.00x | 23.55x | 7.65x | 2.25x | $257.78M | 2.49% | $1.36B | 46.03 | $9.98B | 42.77 | ||
| VCEL | VERICEL CORP | $39.08 | $8.49 | 360.20% | 81.42x | 69.82x | 6.52x | 5.41x | 2.00x | $61.66M | 3.09% | $370.04M | 7.25 | $1.97B | 44.69 | ||
| TGTX | TG THERAPEUTICS INC | $55.74 | $23.81 | 134.07% | 18.10x | 56.09x | 9.88x | 14.12x | 2.02x | $17.39M | 0.22% | $604.08M | 4.26 | $8.80B | 63.22 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $64.63 | $20.01 | 223.05% | 170.08x | 22.20x | 3.67x | 1.98x | 1.12x | $738.18M | 5.90% | $6.32B | 32.68 | $15.82B | 41.02 | ||
| TECH | BIO-TECHNE CORP | $72.31 | $17.40 | 315.49% | 61.80x | 34.63x | 9.28x | 5.38x | 1.95x | $263.22M | 2.33% | $2.11B | 13.52 | $11.36B | 32.69 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.68 | $8.08 | 56.79% | 13.34x | 11.65x | 5.51x | 3.46x | 1.16x | $82.01M | 10.93% | $217.65M | 3.68 | $608.86M | 7.87 | ||
| ADMA | ADMA BIOLOGICS INC | $9.54 | $7.41 | 28.71% | 13.25x | 11.99x | 4.25x | 5.23x | 0.77x | $116.47M | 5.35% | $408.21M | 1.79 | $2.20B | 9.44 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $240.07 | $189.07 | 26.98% | 15.73x | 9.40x | 3.30x | 3.25x | 0.66x | $1.62B | 10.67% | $4.80B | 75.98 | $18.36B | 11.36 | ||
| EXEL | EXELIXIS INC | $57.67 | $31.83 | 81.20% | 17.53x | 17.46x | 5.94x | 7.75x | 1.16x | $1.17B | 8.11% | $1.84B | 7.35 | $14.17B | 13.03 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.19 | $6.31 | -81.15% | 8.50x | -4.02x | 1.47x | 1.57x | 0.07x | $19.58M | 28.40% | $44.20M | 0.76 | $20.57M | 2.69 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $288.83 | $91.28 | 216.42% | 28.68x | 30.57x | 19.95x | 5.95x | 2.17x | $130.62M | 2.25% | $967.52M | 48.22 | $5.88B | 21.09 | ||
| MDXG | MIMEDX GROUP INC | $4.67 | $1.51 | 208.44% | 116.75x | -33.29x | 1.94x | 3.15x | 1.11x | $44.50M | 6.45% | $216.00M | 1.46 | $562.07M | 24.64 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $528.90 | $161.65 | 227.20% | 30.52x | 27.51x | 10.66x | 6.62x | 2.17x | $3.80B | 2.83% | $20.25B | 79.81 | $129.89B | 23.60 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $810.31 | $453.11 | 78.83% | 19.32x | 14.52x | 5.36x | 2.63x | 1.03x | $3.76B | 4.51% | $31.71B | 308.48 | $83.68B | 14.55 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $42.07 | $31.97 | 31.61% | 13.40x | 10.09x | 2.54x | 2.45x | 0.80x | $354.90M | 14.56% | $999.24M | 17.25 | $2.05B | 7.34 | ||
| UTHR | UNITED THERAPEUTICS CORP | $497.97 | $203.49 | 144.71% | 16.47x | 18.59x | 6.72x | 3.34x | 2.85x | $1.09B | 5.15% | $6.40B | 150.24 | $19.56B | 11.66 | ||
| INCY | INCYTE CORP | $124.40 | $62.57 | 98.81% | 15.32x | 35.09x | 4.28x | 3.97x | 1.72x | $1.92B | 7.70% | $6.34B | 31.66 | $21.26B | 10.28 | ||
| VCYT | VERACYTE INC | $42.45 | $7.19 | 490.17% | 29.48x | 40.60x | 6.04x | 2.46x | 117.25x | $165.99M | 4.89% | $1.39B | 17.36 | $3.15B | 22.56 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.